The Effect of Intrathecal Administration of Muscimol on Modulation of Neuropathic Pain Symptoms Resulting from Spinal Cord Injury; an Experimental Study

  • Marjan Hosseini
  • Zohreh Karami
  • Atousa Janzadenh
  • Seyed Behnamedin Jameie
  • Zahra Haji Mashadi
  • Mahmoud Yousefifard
  • Farinaz Nasirinezhad
Publication date
September 2014
Publisher
Shahid Beheshti University of Medical Sciences
Journal
2345-4571

Abstract

<p><strong>Introduction:</strong> Neuropathic pain can be very difficult to treat and it is one of the important medical challenging about pain treatments. Muscimol as a new agonist of gamma-Aminobutyric acid receptor type A (GABA<sub>A</sub>) have been introduced for pain management. Thus, the present study was performed to evaluate the pain alleviating effect of intrathecal injection of different doses of muscimol as GABA<sub>A</sub> receptor agonist in spinal cord injury (SCI) model of neuropathic pain. <strong>Methods:</strong> In the present experimental study male Wistar rats were treated by muscimol 0.01, 0.1 or 1 µg/10ul, intrathecally (i.t.) three weeks after induction of spinal cord injury using compression injury model. Neuropath...

Extracted data

We use cookies to provide a better user experience.